Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Diclofenac and Vitamin D3 for Basal Cell Carcinoma
2010-022410-11Phase 4Active
- Sponsor
- Maastricht University Medical Center+
- Start
- Oct 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of diclofenac and calcitriol in basal cell carcinoma (BCC) (3 arms), sponsored by Maastricht University Medical Center+. Primary endpoint: Histological change in antibody expression. Started Oct 2010; status: active.
02
Drugs
diclofenaccalcitriol
03
Conditions
basal cell carcinoma (BCC)
Beyond the preview
Go deeper on 2010-022410-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022410-11.